Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost ...

Researchers have used an experimental mRNA therapy to make old immune cells in mice behave as if they were young again, ...

Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the “immune imprinting” issue that has contributed to the declining effectiveness of boosters as the virus mutates.

SARS-CoV-2 S–Specific Immune Responses. Credit: DOI: 10.1056/NEJMoa2116747 A coronavirus booster shot provides a better immune response against COVID-19 than a single vaccine dose. mRNA boosters are ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Effectiveness didn't ...

CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 ...

The United States is launching a new distribution program for Covid-19 booster shots — and if you're one of the nearly 14 million people who got the one-shot Johnson & Johnson vaccine, you probably ...